These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis. Manna SK; Mukhopadhyay A; Van NT; Aggarwal BB J Immunol; 1999 Dec; 163(12):6800-9. PubMed ID: 10586080 [TBL] [Abstract][Full Text] [Related]
7. Thalidomide suppresses NF-kappa B activation induced by TNF and H2O2, but not that activated by ceramide, lipopolysaccharides, or phorbol ester. Majumdar S; Lamothe B; Aggarwal BB J Immunol; 2002 Mar; 168(6):2644-51. PubMed ID: 11884428 [TBL] [Abstract][Full Text] [Related]
8. Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase. Manna SK; Sah NK; Newman RA; Cisneros A; Aggarwal BB Cancer Res; 2000 Jul; 60(14):3838-47. PubMed ID: 10919658 [TBL] [Abstract][Full Text] [Related]
9. Adenosine suppresses activation of nuclear factor-kappaB selectively induced by tumor necrosis factor in different cell types. Majumdar S; Aggarwal BB Oncogene; 2003 Feb; 22(8):1206-18. PubMed ID: 12606947 [TBL] [Abstract][Full Text] [Related]
10. IFN-alpha suppresses activation of nuclear transcription factors NF-kappa B and activator protein 1 and potentiates TNF-induced apoptosis. Manna SK; Mukhopadhyay A; Aggarwal BB J Immunol; 2000 Nov; 165(9):4927-34. PubMed ID: 11046018 [TBL] [Abstract][Full Text] [Related]
11. Calagualine inhibits nuclear transcription factors-kappaB activated by various inflammatory and tumor promoting agents. Manna SK; Bueso-Ramos C; Alvarado F; Aggarwal BB Cancer Lett; 2003 Feb; 190(2):171-82. PubMed ID: 12565172 [TBL] [Abstract][Full Text] [Related]
12. Antigen-receptor cross-linking and lipopolysaccharide trigger distinct phosphoinositide 3-kinase-dependent pathways to NF-kappa B activation in primary B cells. Bone H; Williams NA Int Immunol; 2001 Jun; 13(6):807-16. PubMed ID: 11369709 [TBL] [Abstract][Full Text] [Related]